TABLE 2.

The relationship between prognosis with variable.

	≤2 days (n = 63)	>2 days (n = 64)
Gender
Female (%)	23 (36.51)	40 (62.50)
Male (%)	40 (63.49)	24 (37.50)
Age (year)	62.82 ± 1.41	61.39 ± 1.45
Contrast types
Non-ionic (%)	46 (73.02)	51 (79.69)
Ionic (%)	12 (19.05)	6 (9.38)
Low-osmolar (%)	45 (71.43)	35 (54.69)
High-osmolar (%)	8 (12.70)	7 (10.94)
Iso-osmolal (%)	4 (6.35)	11 (17.19)
Contrast doses (ml)	188.60 ± 13.99	198.07 ± 14.23
Non-ionic (ml)	193.39 ± 15.59	199.19 ± 14.73
Ionic (ml)	167.70 ± 37.91	235.20 ± 54.49
Low-osmolar (ml)	195.10 ± 16.18	207.83 ± 19.85
High-osmolar (ml)	117.83 ± 35.31	194.20 ± 45.73
Iso-osmolal (ml)	167.50 ± 58.79	152.56 ± 23.40
Comorbidities
Hypertension (%)	32 (50.79)	39 (60.93)
Diabetes mellitus (%)	10 (15.78)	16 (25.00)
History of angiography (%)	9 (14.29) + 1	11 (17.19)
Renal impairment (%)	6 (9.52)	9 (14.06)
Dyslipidaemia (%)	2 (3.17)	3 (4.69)
Angiography types
Coronary angiography (%)	49 (77.78)	23 (35.94)
Cerebral angiography (%)	6 (9.52)	24 (37.50)
Carotid and vertebral angiography (%)	6 (9.52)	4 (6.25)
Abnormal CT or MRI (%)	40 (63.49)	44 (68.75)